Paul Read's progress in the trial marks a significant breakthrough, where his glioblastoma brain tumour was reduced by half within weeks thanks to innovative radioactive therapy.
The results of the trial were deemed "remarkable for somebody whose tumour is so aggressive" highlighting the potential of this new targeted treatment.
Dr. Paul Mulholland emphasized the effectiveness of the new therapy, explaining how it directly targets tumour cells, sparing healthy tissue while delivering lethal damage.
Mr. Read showed resilience despite his diagnosis, noting that he was open to exploring all treatment options regardless of the outcome, expressing hope for future patients.
Collection
[
|
...
]